NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
IR Overview News / Events / Webcasts Presentations Press Releases IR Calendar Email Alerts.
Source: pressreleasepoint.com
📰 Pathology Certification News
Pathology Certification News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pathology Certification. Real-time updates on events, politics, business and more.
NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
13.12.2021 - FT MYERS, FL / ACCESSWIRE / December 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced the appointment of David Eberhard MD, PhD ... Seite 1
United States Clive Morris Neogenomics Inc Oncology Development At Genomic Health University Of South Dakota Inivata Limited
Source: wallstreet-online.de